Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;30(3):2591-2604.
doi: 10.1007/s00520-021-06663-2. Epub 2021 Nov 23.

Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study

Affiliations

Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study

Pierre Nizet et al. Support Care Cancer. 2022 Mar.

Abstract

Purpose: The aim of this study was to explore the beliefs, perceptions and representations of patients in order to identify the determinants of oral anticancer drugs adherence and to take action in current practice to improve patient support in digestive oncology.

Methods: We constructed a semi-directed interview guide which aimed to explore the patient's relationship with medication, their health history, their experiences at the time of the announcement of treatment, their confidence, their fears, their motivations to adhere to their treatment and the constraints linked to their treatment. The data were analysed and discussed using a thematic approach.

Results: Seventeen patients agreed to participate in the study. The median age was 60 years. Ten patients had colorectal cancer, 3 patients had hepatocellular carcinoma, 3 patients had gastrointestinal stromal tumour and 1 patient had neuroendocrine pancreatic tumour. We identified five categories of factors influencing adherence: demographic and socioeconomic, disease-related, treatment-related, care system-related, and patient representation and pathways' factors. A majority of patients emphasised the importance of family support in the adherence process and the convenience of per os treatment compared to other intravenous treatments. However, several negative determinants emerged such as the toxicity of the treatment, fears of forgetting to take the medication, difficulties with the galenic formulation and negative beliefs of the family.

Conclusion: This study demonstrates the need to address the different dimensions of the patient in order to understand his or her behaviour with regard to adherence and to identify the levers for improvement.

Keywords: Adherence; Oral anticancer drugs; Patient experience; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Haynes RB, Taylor DW, Sackett DL, éditeurs. Compliance in health care. Baltimore: Johns Hopkins University Press; 1979.
    1. Allenet B, Lehmann A, Baudrant M, Gauchet A. Il nous faut arrêter de parler du patient « non observant » à ses traitements mais plutôt d’un patient présentant des difficultés d’adhésion médicamenteuse. Annales Pharmaceutiques Françaises. 2018;76(6):489–98. doi: 10.1016/j.pharma.2018.07.006. - DOI - PubMed
    1. Beauvais C. 2007 Quand prescrire ne suffit plus… L’observance thérapeutique: un enjeu pour les rhumatologues – adherence to medication: a challenge for patients and rheumatologists. É ditorial. déc;4.
    1. Adhésion, observance et persistance thérapeutiques: de quoi parle-t-on? [Internet]. WeLL. 2018 [cité 21 mars 2021]. Disponible sur: http://well-livinglab.be/adhesion-observance-persistance-therapeutique-d...
    1. Allenet B, Baudrant M, Lehmann A, Gauchet A, Roustit M, Bedouch P, et al. Comment évaluer l’adhésion médicamenteuse ? Le point sur les méthodes. Annales Pharmaceutiques Françaises. 2013;71(2):135–41. doi: 10.1016/j.pharma.2012.10.001. - DOI - PubMed

Substances